APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liver AI-assisted Diagnosis

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Liver AI-assisted Diagnosis Market Analysis and Forecast 2026-2032

6 March 2026199 pages

Choose your research edition.

Industry ResearchLiver AI-assisted Diagnosis Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Liver AI-assisted Diagnosis Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Liver AI-assisted Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liver AI-assisted Diagnosis Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Liver AI-assisted Diagnosis Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Liver AI-assisted Diagnosis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Liver AI-assisted Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Liver AI-assisted Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Liver AI-assisted Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Liver AI-assisted Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Liver AI-assisted Diagnosis include NANO-X, Sense Time, Shukun, VoxelCloud, G K Healthcare, GE HealthCare, zyheal, PathAI and Human Metabolomics lnstitute, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Liver AI-assisted Diagnosis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Liver AI-assisted Diagnosis, also provides the revenue of main regions and countries. Of the upcoming market potential for Liver AI-assisted Diagnosis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liver AI-assisted Diagnosis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Liver AI-assisted Diagnosis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Liver AI-assisted Diagnosis revenue, projected growth trends, production technology, application and end-user industry.

Liver AI-assisted Diagnosis Segment by Company

NANO-X

Sense Time

Shukun

VoxelCloud

G K Healthcare

GE HealthCare

zyheal

PathAI

Human Metabolomics lnstitute

ASTRI

Liver AI-assisted Diagnosis Segment by Type

Cloud-based

On-Primes

Liver AI-assisted Diagnosis Segment by Application

Hospital

Clinic

Imaging Center

Liver AI-assisted Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liver AI-assisted Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liver AI-assisted Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liver AI-assisted Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Liver AI-assisted Diagnosis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Liver AI-assisted Diagnosis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liver AI-assisted Diagnosis revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Liver AI-assisted Diagnosis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud-based Major Player Table 3. On-Primes Major Player Table 4. Global Liver AI-assisted Diagnosis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Imaging Center Major Player Table 8. Liver AI-assisted Diagnosis Industry Trends Table 9. Liver AI-assisted Diagnosis Industry Drivers Table 10. Liver AI-assisted Diagnosis Industry Opportunities and Challenges Table 11. Liver AI-assisted Diagnosis Industry Restraints Table 12. Global Liver AI-assisted Diagnosis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Liver AI-assisted Diagnosis Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Liver AI-assisted Diagnosis Market Share by Region (2021-2026) Table 15. Global Liver AI-assisted Diagnosis Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Liver AI-assisted Diagnosis Market Share by Region (2027-2032) Table 17. Global Liver AI-assisted Diagnosis Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Liver AI-assisted Diagnosis Revenue Market Share by Players (2021-2026) Table 19. Global Liver AI-assisted Diagnosis Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Liver AI-assisted Diagnosis Key Players Headquarters & Area Served Table 21. Global Liver AI-assisted Diagnosis Players, Product Type & Application Table 22. Global Liver AI-assisted Diagnosis Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Liver AI-assisted Diagnosis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Liver AI-assisted Diagnosis Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Liver AI-assisted Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Liver AI-assisted Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Liver AI-assisted Diagnosis Revenue Market Share by Type (2021-2026) Table 29. Global Liver AI-assisted Diagnosis Revenue Market Share by Type (2027-2032) Table 30. Global Liver AI-assisted Diagnosis Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Liver AI-assisted Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Liver AI-assisted Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Liver AI-assisted Diagnosis Revenue Market Share by Application (2021-2026) Table 34. Global Liver AI-assisted Diagnosis Revenue Market Share by Application (2027-2032) Table 35. NANO-X Company Information Table 36. NANO-X Business Overview Table 37. NANO-X Liver AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. NANO-X Liver AI-assisted Diagnosis Product Portfolio Table 39. NANO-X Recent Development Table 40. Sense Time Company Information Table 41. Sense Time Business Overview Table 42. Sense Time Liver AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Sense Time Liver AI-assisted Diagnosis Product Portfolio Table 44. Sense Time Recent Development Table 45. Shukun Company Information Table 46. Shukun Business Overview Table 47. Shukun Liver AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Shukun Liver AI-assisted Diagnosis Product Portfolio Table 49. Shukun Recent Development Table 50. VoxelCloud Company Information Table 51. VoxelCloud Business Overview Table 52. VoxelCloud Liver AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. VoxelCloud Liver AI-assisted Diagnosis Product Portfolio Table 54. VoxelCloud Recent Development Table 55. G K Healthcare Company Information Table 56. G K Healthcare Business Overview Table 57. G K Healthcare Liver AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. G K Healthcare Liver AI-assisted Diagnosis Product Portfolio Table 59. G K Healthcare Recent Development Table 60. GE HealthCare Company Information Table 61. GE HealthCare Business Overview Table 62. GE HealthCare Liver AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. GE HealthCare Liver AI-assisted Diagnosis Product Portfolio Table 64. GE HealthCare Recent Development Table 65. zyheal Company Information Table 66. zyheal Business Overview Table 67. zyheal Liver AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. zyheal Liver AI-assisted Diagnosis Product Portfolio Table 69. zyheal Recent Development Table 70. PathAI Company Information Table 71. PathAI Business Overview Table 72. PathAI Liver AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. PathAI Liver AI-assisted Diagnosis Product Portfolio Table 74. PathAI Recent Development Table 75. Human Metabolomics lnstitute Company Information Table 76. Human Metabolomics lnstitute Business Overview Table 77. Human Metabolomics lnstitute Liver AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Human Metabolomics lnstitute Liver AI-assisted Diagnosis Product Portfolio Table 79. Human Metabolomics lnstitute Recent Development Table 80. ASTRI Company Information Table 81. ASTRI Business Overview Table 82. ASTRI Liver AI-assisted Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. ASTRI Liver AI-assisted Diagnosis Product Portfolio Table 84. ASTRI Recent Development Table 85. North America Liver AI-assisted Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 86. North America Liver AI-assisted Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 87. North America Liver AI-assisted Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Liver AI-assisted Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Liver AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Liver AI-assisted Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Liver AI-assisted Diagnosis Revenue by Country (US$ Million) & (2027-2032) Table 92. Europe Liver AI-assisted Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 93. Europe Liver AI-assisted Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 94. Europe Liver AI-assisted Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 95. Europe Liver AI-assisted Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 96. Europe Liver AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Liver AI-assisted Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 98. Europe Liver AI-assisted Diagnosis Revenue by Country (US$ Million) & (2027-2032) Table 99. China Liver AI-assisted Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 100. China Liver AI-assisted Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 101. China Liver AI-assisted Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 102. China Liver AI-assisted Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia Liver AI-assisted Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 104. Asia Liver AI-assisted Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 105. Asia Liver AI-assisted Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 106. Asia Liver AI-assisted Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia Liver AI-assisted Diagnosis Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Liver AI-assisted Diagnosis Revenue by Region (US$ Million) & (2021-2026) Table 109. Asia Liver AI-assisted Diagnosis Revenue by Region (US$ Million) & (2027-2032) Table 110. SAMEA Liver AI-assisted Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 111. SAMEA Liver AI-assisted Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 112. SAMEA Liver AI-assisted Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 113. SAMEA Liver AI-assisted Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 114. SAMEA Liver AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. SAMEA Liver AI-assisted Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 116. SAMEA Liver AI-assisted Diagnosis Revenue by Country (US$ Million) & (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Liver AI-assisted Diagnosis Image Figure 2. Global Liver AI-assisted Diagnosis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liver AI-assisted Diagnosis Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud-based Image Figure 5. On-Primes Image Figure 6. Global Liver AI-assisted Diagnosis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Liver AI-assisted Diagnosis Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Imaging Center Image Figure 11. Global Liver AI-assisted Diagnosis Market Size (US$ Million) & (2021-2032) Figure 12. Global Liver AI-assisted Diagnosis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Liver AI-assisted Diagnosis Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Liver AI-assisted Diagnosis Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Liver AI-assisted Diagnosis Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Liver AI-assisted Diagnosis Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Liver AI-assisted Diagnosis Revenue Market Share by Type (2021-2032) Figure 19. Global Liver AI-assisted Diagnosis Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Liver AI-assisted Diagnosis Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Liver AI-assisted Diagnosis Revenue Market Share by Application (2021-2032) Figure 22. North America Liver AI-assisted Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Liver AI-assisted Diagnosis Revenue Share by Type (2021-2032) Figure 24. North America Liver AI-assisted Diagnosis Revenue Share by Application (2021-2032) Figure 25. North America Liver AI-assisted Diagnosis Revenue Share by Country (2021-2032) Figure 26. United States Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Liver AI-assisted Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Liver AI-assisted Diagnosis Revenue Share by Type (2021-2032) Figure 31. Europe Liver AI-assisted Diagnosis Revenue Share by Application (2021-2032) Figure 32. Europe Liver AI-assisted Diagnosis Revenue Share by Country (2021-2032) Figure 33. Germany Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Liver AI-assisted Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Liver AI-assisted Diagnosis Revenue Share by Type (2021-2032) Figure 43. China Liver AI-assisted Diagnosis Revenue Share by Application (2021-2032) Figure 44. Asia Liver AI-assisted Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Liver AI-assisted Diagnosis Revenue Share by Type (2021-2032) Figure 46. Asia Liver AI-assisted Diagnosis Revenue Share by Application (2021-2032) Figure 47. Asia Liver AI-assisted Diagnosis Revenue Share by Region (2021-2032) Figure 48. Japan Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Liver AI-assisted Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Liver AI-assisted Diagnosis Revenue Share by Type (2021-2032) Figure 56. SAMEA Liver AI-assisted Diagnosis Revenue Share by Application (2021-2032) Figure 57. SAMEA Liver AI-assisted Diagnosis Revenue Share by Country (2021-2032) Figure 58. Brazil Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Liver AI-assisted Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-Primes
Applications
  • Hospital
  • Clinic
  • Imaging Center
Companies covered
  • NANO-X
  • Sense Time
  • Shukun
  • VoxelCloud
  • G K Healthcare
  • GE HealthCare
  • zyheal
  • PathAI
  • Human Metabolomics lnstitute
  • ASTRI

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Liver AI-assisted Diagnosis Market by Type
  3. 1.2.1 Global Liver AI-assisted Diagnosis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-based
  5. 1.2.3 On-Primes
  6. 1.3 Liver AI-assisted Diagnosis Market by Application
  7. 1.3.1 Global Liver AI-assisted Diagnosis Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Imaging Center
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Liver AI-assisted Diagnosis Market Dynamics
  1. 2.1 Liver AI-assisted Diagnosis Industry Trends
  2. 2.2 Liver AI-assisted Diagnosis Industry Drivers
  3. 2.3 Liver AI-assisted Diagnosis Industry Opportunities and Challenges
  4. 2.4 Liver AI-assisted Diagnosis Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Liver AI-assisted Diagnosis Market Perspective (2021-2032)
  2. 3.2 Global Liver AI-assisted Diagnosis Growth Trends by Region
  3. 3.2.1 Global Liver AI-assisted Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Liver AI-assisted Diagnosis Market Size by Region (2021-2026)
  5. 3.2.3 Global Liver AI-assisted Diagnosis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Liver AI-assisted Diagnosis Revenue by Players
  2. 4.1.1 Global Liver AI-assisted Diagnosis Revenue by Players (2021-2026)
  3. 4.1.2 Global Liver AI-assisted Diagnosis Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Liver AI-assisted Diagnosis Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Liver AI-assisted Diagnosis Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Liver AI-assisted Diagnosis Key Players Headquarters & Area Served
  7. 4.4 Global Liver AI-assisted Diagnosis Players, Product Type & Application
  8. 4.5 Global Liver AI-assisted Diagnosis Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Liver AI-assisted Diagnosis Market CR5 and HHI
  11. 4.6.3 2025 Liver AI-assisted Diagnosis Tier 1, Tier 2, and Tier 3
5 Liver AI-assisted Diagnosis Market Size by Type
  1. 5.1 Global Liver AI-assisted Diagnosis Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Liver AI-assisted Diagnosis Revenue by Type (2021-2032)
  3. 5.3 Global Liver AI-assisted Diagnosis Revenue Market Share by Type (2021-2032)
6 Liver AI-assisted Diagnosis Market Size by Application
  1. 6.1 Global Liver AI-assisted Diagnosis Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Liver AI-assisted Diagnosis Revenue by Application (2021-2032)
  3. 6.3 Global Liver AI-assisted Diagnosis Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 NANO-X
  2. 7.1.1 NANO-X Company Information
  3. 7.1.2 NANO-X Business Overview
  4. 7.1.3 NANO-X Liver AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  5. 7.1.4 NANO-X Liver AI-assisted Diagnosis Product Portfolio
  6. 7.1.5 NANO-X Recent Developments
  7. 7.2 Sense Time
  8. 7.2.1 Sense Time Company Information
  9. 7.2.2 Sense Time Business Overview
  10. 7.2.3 Sense Time Liver AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Sense Time Liver AI-assisted Diagnosis Product Portfolio
  12. 7.2.5 Sense Time Recent Developments
  13. 7.3 Shukun
  14. 7.3.1 Shukun Company Information
  15. 7.3.2 Shukun Business Overview
  16. 7.3.3 Shukun Liver AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Shukun Liver AI-assisted Diagnosis Product Portfolio
  18. 7.3.5 Shukun Recent Developments
  19. 7.4 VoxelCloud
  20. 7.4.1 VoxelCloud Company Information
  21. 7.4.2 VoxelCloud Business Overview
  22. 7.4.3 VoxelCloud Liver AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  23. 7.4.4 VoxelCloud Liver AI-assisted Diagnosis Product Portfolio
  24. 7.4.5 VoxelCloud Recent Developments
  25. 7.5 G K Healthcare
  26. 7.5.1 G K Healthcare Company Information
  27. 7.5.2 G K Healthcare Business Overview
  28. 7.5.3 G K Healthcare Liver AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  29. 7.5.4 G K Healthcare Liver AI-assisted Diagnosis Product Portfolio
  30. 7.5.5 G K Healthcare Recent Developments
  31. 7.6 GE HealthCare
  32. 7.6.1 GE HealthCare Company Information
  33. 7.6.2 GE HealthCare Business Overview
  34. 7.6.3 GE HealthCare Liver AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  35. 7.6.4 GE HealthCare Liver AI-assisted Diagnosis Product Portfolio
  36. 7.6.5 GE HealthCare Recent Developments
  37. 7.7 zyheal
  38. 7.7.1 zyheal Company Information
  39. 7.7.2 zyheal Business Overview
  40. 7.7.3 zyheal Liver AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  41. 7.7.4 zyheal Liver AI-assisted Diagnosis Product Portfolio
  42. 7.7.5 zyheal Recent Developments
  43. 7.8 PathAI
  44. 7.8.1 PathAI Company Information
  45. 7.8.2 PathAI Business Overview
  46. 7.8.3 PathAI Liver AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  47. 7.8.4 PathAI Liver AI-assisted Diagnosis Product Portfolio
  48. 7.8.5 PathAI Recent Developments
  49. 7.9 Human Metabolomics lnstitute
  50. 7.9.1 Human Metabolomics lnstitute Company Information
  51. 7.9.2 Human Metabolomics lnstitute Business Overview
  52. 7.9.3 Human Metabolomics lnstitute Liver AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Human Metabolomics lnstitute Liver AI-assisted Diagnosis Product Portfolio
  54. 7.9.5 Human Metabolomics lnstitute Recent Developments
  55. 7.10 ASTRI
  56. 7.10.1 ASTRI Company Information
  57. 7.10.2 ASTRI Business Overview
  58. 7.10.3 ASTRI Liver AI-assisted Diagnosis Revenue and Gross Margin (2021-2026)
  59. 7.10.4 ASTRI Liver AI-assisted Diagnosis Product Portfolio
  60. 7.10.5 ASTRI Recent Developments
8 North America
  1. 8.1 North America Liver AI-assisted Diagnosis Revenue (2021-2032)
  2. 8.2 North America Liver AI-assisted Diagnosis Revenue by Type (2021-2032)
  3. 8.2.1 North America Liver AI-assisted Diagnosis Revenue by Type (2021-2026)
  4. 8.2.2 North America Liver AI-assisted Diagnosis Revenue by Type (2027-2032)
  5. 8.3 North America Liver AI-assisted Diagnosis Revenue Share by Type (2021-2032)
  6. 8.4 North America Liver AI-assisted Diagnosis Revenue by Application (2021-2032)
  7. 8.4.1 North America Liver AI-assisted Diagnosis Revenue by Application (2021-2026)
  8. 8.4.2 North America Liver AI-assisted Diagnosis Revenue by Application (2027-2032)
  9. 8.5 North America Liver AI-assisted Diagnosis Revenue Share by Application (2021-2032)
  10. 8.6 North America Liver AI-assisted Diagnosis Revenue by Country
  11. 8.6.1 North America Liver AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Liver AI-assisted Diagnosis Revenue by Country (2021-2026)
  13. 8.6.3 North America Liver AI-assisted Diagnosis Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Liver AI-assisted Diagnosis Revenue (2021-2032)
  2. 9.2 Europe Liver AI-assisted Diagnosis Revenue by Type (2021-2032)
  3. 9.2.1 Europe Liver AI-assisted Diagnosis Revenue by Type (2021-2026)
  4. 9.2.2 Europe Liver AI-assisted Diagnosis Revenue by Type (2027-2032)
  5. 9.3 Europe Liver AI-assisted Diagnosis Revenue Share by Type (2021-2032)
  6. 9.4 Europe Liver AI-assisted Diagnosis Revenue by Application (2021-2032)
  7. 9.4.1 Europe Liver AI-assisted Diagnosis Revenue by Application (2021-2026)
  8. 9.4.2 Europe Liver AI-assisted Diagnosis Revenue by Application (2027-2032)
  9. 9.5 Europe Liver AI-assisted Diagnosis Revenue Share by Application (2021-2032)
  10. 9.6 Europe Liver AI-assisted Diagnosis Revenue by Country
  11. 9.6.1 Europe Liver AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Liver AI-assisted Diagnosis Revenue by Country (2021-2026)
  13. 9.6.3 Europe Liver AI-assisted Diagnosis Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Liver AI-assisted Diagnosis Revenue (2021-2032)
  2. 10.2 China Liver AI-assisted Diagnosis Revenue by Type (2021-2032)
  3. 10.2.1 China Liver AI-assisted Diagnosis Revenue by Type (2021-2026)
  4. 10.2.2 China Liver AI-assisted Diagnosis Revenue by Type (2027-2032)
  5. 10.3 China Liver AI-assisted Diagnosis Revenue Share by Type (2021-2032)
  6. 10.4 China Liver AI-assisted Diagnosis Revenue by Application (2021-2032)
  7. 10.4.1 China Liver AI-assisted Diagnosis Revenue by Application (2021-2026)
  8. 10.4.2 China Liver AI-assisted Diagnosis Revenue by Application (2027-2032)
  9. 10.5 China Liver AI-assisted Diagnosis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Liver AI-assisted Diagnosis Revenue (2021-2032)
  2. 11.2 Asia Liver AI-assisted Diagnosis Revenue by Type (2021-2032)
  3. 11.2.1 Asia Liver AI-assisted Diagnosis Revenue by Type (2021-2026)
  4. 11.2.2 Asia Liver AI-assisted Diagnosis Revenue by Type (2027-2032)
  5. 11.3 Asia Liver AI-assisted Diagnosis Revenue Share by Type (2021-2032)
  6. 11.4 Asia Liver AI-assisted Diagnosis Revenue by Application (2021-2032)
  7. 11.4.1 Asia Liver AI-assisted Diagnosis Revenue by Application (2021-2026)
  8. 11.4.2 Asia Liver AI-assisted Diagnosis Revenue by Application (2027-2032)
  9. 11.5 Asia Liver AI-assisted Diagnosis Revenue Share by Application (2021-2032)
  10. 11.6 Asia Liver AI-assisted Diagnosis Revenue by Country
  11. 11.6.1 Asia Liver AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Liver AI-assisted Diagnosis Revenue by Country (2021-2026)
  13. 11.6.3 Asia Liver AI-assisted Diagnosis Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Liver AI-assisted Diagnosis Revenue (2021-2032)
  2. 12.2 SAMEA Liver AI-assisted Diagnosis Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Liver AI-assisted Diagnosis Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Liver AI-assisted Diagnosis Revenue by Type (2027-2032)
  5. 12.3 SAMEA Liver AI-assisted Diagnosis Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Liver AI-assisted Diagnosis Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Liver AI-assisted Diagnosis Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Liver AI-assisted Diagnosis Revenue by Application (2027-2032)
  9. 12.5 SAMEA Liver AI-assisted Diagnosis Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Liver AI-assisted Diagnosis Revenue by Country
  11. 12.6.1 SAMEA Liver AI-assisted Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Liver AI-assisted Diagnosis Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Liver AI-assisted Diagnosis Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst